Evidence map›Paper›PMID 32655969›Full record

ReviewImmune network2020

TLR10 and Its Unique Anti-Inflammatory Properties and Potential Use as a Target in Therapeutics.

Faith Fore, Cut Indriputri, Janet Mamutse, Jusak Nugraha

Open access · diamondAbstract readReview
In one paragraph

Review in Immune network, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 94 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Recent Advances in Host Immune Mechanisms AgainstJournal of inflammation research · 2025
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Faith ForeDepartment of Immunology, Postgraduate School, Universitas Airlangga, Surabaya 60285, Indonesia.ORCID https://orcid.org/0000-0002-2804-6444
Cut IndriputriDepartment of Immunology, Postgraduate School, Universitas Airlangga, Surabaya 60285, Indonesia.ORCID https://orcid.org/0000-0002-4182-0203
Janet MamutseDepartment of Animal Breeding and Genetics, Faculty of Animal Science, University of Jenderal Soedirman, Purworkerto 53122, Indonesia.ORCID https://orcid.org/0000-0003-3833-2994
Jusak NugrahaPostgraduate School, Universitas Airlangga, Surabaya 60285, Indonesia.ORCID https://orcid.org/0000-0001-6700-9921
Airlangga University · IDJenderal Soedirman University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TLRs are pattern recognition receptors (PRRs) whose cytoplasmic signalling domain is similar to that of IL-1. The extracellular domain of TLRs serve as the binding site of pathogen associated molecular patterns. TLRs are found on both plasma and endosomal membranes and they mainly exert their function by activating genes which lead to production of inflammatory factors. The latest TLR to be discovered, TLR10 is a unique TLR which exhibit anti-inflammatory properties. TLR10 is found on the plasma membrane with other TLRs namely TLR1, TLR2, TLR4, TLR5 and TLR6. Studies have revealed that TLR10 is found on the same gene cluster with TLR1 and TLR6 and is also a coreceptor of TLR2. Up to date, TLR10 is the only TLR which exhibit anti-inflammatory property. Previously, TLR10 was thought to be an "orphan receptor" but much recent studies have identified ligands for TLR10. Currently there is no review article on TLR10 that has been published. In this narrative review, we are going to give an account of TLR10, its functions mainly as an anti-inflammatory PRR and its possible applications as a target in therapeutics.

Indexed as

Anti-inflammatoryPolymorphismTLR10 ligandsToll-like receptor 10

Identifiers

PMID32655969
PMCPMC7327153
OpenAlexW3021537403

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.